Torfs K
Health Economics Unit, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Eur J Clin Microbiol Infect Dis. 1997 Jan;16(1):98-107. doi: 10.1007/BF01575127.
Although health care expenditure has increased steadily over the past decennium, the general feeling is that resources are more limited than ever. One reason for this may be that the range of treatment options has grown so wide that the need to make rational choices has become apparent. Since treatments vary with respect to both effectiveness and cost, economic evaluations are becoming an important tool for assessing new and existing treatment strategies. The basic concepts of economic evaluation will be introduced here and the key economic questions with respect to treatment of fungal infections in cancer patients identified. Some of these concepts are explained using findings from a pilot survey carried out among participants in the symposium "Trends in Invasive Fungal Infections-3" 7-9 held September, 1995, in Brussels, Belgium. The conclusion will offer recommendations for assessing economic evaluations.
尽管在过去十年间医疗保健支出稳步增长，但人们普遍感觉资源比以往任何时候都更加有限。造成这种情况的一个原因可能是治疗选择的范围变得如此广泛，以至于做出合理选择的必要性变得显而易见。由于治疗在有效性和成本方面存在差异，经济评估正成为评估新的和现有的治疗策略的重要工具。本文将介绍经济评估的基本概念，并确定与癌症患者真菌感染治疗相关的关键经济问题。其中一些概念将通过对1995年9月7日至9日在比利时布鲁塞尔举行的“侵袭性真菌感染趋势-3”研讨会参与者进行的一项试点调查结果进行解释。结论将为评估经济评估提供建议。
